新北洋(002376.SZ):金融機具產品已拓展至東南亞、南美和一帶一路周邊等新興地區和發展中國家
格隆匯9月25日丨新北洋(002376.SZ)於2024年9月24日接受特定對象調研時表示,金融機具產品,公司的金融機具產品已拓展至東南亞、南美和一帶一路周邊等新興地區和發展中國家,並憑藉國內市場驗證成熟的產品,在海外市場競爭中實現降維打擊,形成了較強的競爭力。同時,公司聚焦“海外商業零售”場景,提供前端和後端,尤其是後端的大額現金存儲解決方案,進一步鞏固了公司的市場規模。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.